Related Experiment Video
Updated: Feb 8, 2026

Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli
Published on: January 6, 2015
Expression and purification of pneumococcal surface protein a of clade 4 in Escherichia coli using hydroxylapatite
Hualong Xi1, Jinfei Yu1, Qing Sun1
1National Engineering Laboratory for AIDS Vaccine, School of Life Science, Jilin University, Changchun, 130012, China.
Insights
A new method efficiently produces and purifies Streptococcus pneumoniae surface protein A (PspA) from E. coli. This advance offers a promising strategy for developing PspA-based vaccines against pneumococcal diseases.
Area of Science:
- Microbiology
- Vaccine Development
- Protein Expression
Background:
- * Streptococcus pneumoniae causes severe diseases globally, particularly in vulnerable populations.
- * Pneumococcal surface protein A (PspA) is a key target for next-generation vaccines.
- * Current vaccines face limitations, driving the need for alternative strategies.
Purpose of the Study:
- * To develop an efficient method for producing and purifying PspA clade 4.
- * To establish a scalable process for recombinant PspA production.
- * To validate the method's applicability to other PspA clades.
Main Methods:
- * Expression of soluble PspA4 in an Escherichia coli system.
- * Purification using hydroxylapatite and ion-exchange chromatography.
- * Characterization of purified PspA4 using circular dichroism and mass spectrometry.
Main Results:
- * Achieved high yields of soluble PspA4 (22.8 mg/L) from autoinducing cultures.
- * Enhanced PspA4 purity from 17% to over 95% in a single chromatographic step.
- * Demonstrated successful purification of recombinant PspA4 with high yield (43%).
Conclusions:
- * A simple and efficient method for mass production of PspA4 was established.
- * The purification technique significantly improves PspA purity.
- * This method is adaptable for producing PspA proteins from diverse clades, aiding vaccine development.
Abstract:
Streptococcus pneumoniae is a major pathogen that causes life-threatening diseases, such as pneumonia, otitis media, bacteremia, and meningitis, worldwide and especially in young children and the elderly. Pneumococcal surface protein A (PspA) is a widely studied candidate protein vaccine that represents a promising replacement for current polysaccharide and polysaccharide-conjugate vaccines. In this study, we describe a simple method to produce PspA of clade 4 from an Escherichia coli expression system using hydroxylapatite and ion-exchange chromatography. Using this method, we successfully expressed soluble PspA4 in 10 L of autoinducing culture medium, with a wet-cell yield of 19 g/L and a final PspA4 concentration of 22.8 mg/L. Additionally, we improved PspA4 purity from 17% to 70% in a single step through the use of hydroxylapatite, resulting in acquisition of recombinant PspA4 (>95% purity) at a final yield of 43% from the starting cell-lysis solution. We subsequently verified the secondary structure molecular weight of recombinant PspA4 by circular dichroism and mass spectrometry, respectively. These results demonstrated a highly efficient method for mass producing PspA4 protein and that can also be applied for purification of PspA proteins from other clades.
Related Concept Videos
Ion-Exchange Chromatography
Ion Exchange
Types Of Column Chromatography
Gel Filtration Chromatography
When the...
Principles Of Column Chromatography
Diffusion on Chromatography Columns
Longitudinal diffusion occurs when the solute molecules in the mobile phase diffuse from the more concentrated center of the chromatographic band to the more dilute regions on either side, both towards and against the flow direction. This...
Silica Gel Column Chromatography: Overview
Polar components tend to bind strongly to the silica gel, causing them to move slowly through the column. In contrast, nonpolar compounds...

